0
Invited Commentary |

When It's the Right Care, More Is Better:  Comment on “Palliative Care and Quality of Life” and “Pain as a Cause of Agitated Delirium”

Steven Z. Pantilat, MD, FAAHPM, SFHM
Arch Intern Med. 2012;172(15):1172-1173. doi:10.1001/archinternmed.2012.2894.
Text Size: A A A
Published online

Extract

The front page of the Wall Street Journal reports that, according to a randomized clinical trial, a new drug, palliatosin, when given to patients with metastatic non–small cell lung cancer, like the patient described by Kirch,1reduces depression, improves quality of life, and, as emblazoned in the headline, lengthens life by 2½ months. Based on the results of this trial, the stock price for the maker of palliatosin rises sharply. Word spreads like wildfire among patients, driving intense demand for palliatosin. The manufacturer struggles to maintain adequate supplies. Palliatosin is hailed as a major breakthrough in cancer care. Although it costs $2000 a month and was tested only in patients with incurable lung cancer, physicians prescribe palliatosin to patients with all types of cancer at all stages based on its impressive impact and complete lack of adverse effects.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination
Make the Diagnosis: Delirium

The Rational Clinical Examination
Original Article: Does This Patient Have Delirium? Value of Bedside Instruments

brightcove.createExperiences();